Elpamotide
Elpamotide Uses, Dosage, Side Effects, Food Interaction and all others data.
Elpamotide is under investigation in clinical trial NCT00655785 (Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer (Phase1/2)).
| Trade Name | Elpamotide |
| Generic | VEGFR2-169 |
| VEGFR2-169 Other Names | Elpamotide, Vegfr2-169 peptide vaccine |
| Type | |
| Formula | C47H76N16O13 |
| Weight | Average: 1073.224 Monoisotopic: 1072.577776571 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Elpamotide
